FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2023642966> ?p ?o ?g. }

• W2023642966 endingPage "1175" @default.
• W2023642966 startingPage "1169" @default.
• W2023642966 abstract "Other than lung transplantation (LT), no specific therapies exist for end-stage lung disease resulting from hematopoietic stem cell transplantation (HCT)-related complications, such as bronchiolitis obliterans syndrome (BOS). We report the indications and outcomes in patients who underwent LT after HCT for hematologic disease from a retrospective case series at our institution and a review of the medical literature. We identified a total of 70 cases of LT after HCT, including 9 allogeneic HCT recipients from our institution who underwent LT between 1990 and 2010. In our cohort, the median age was 16 years (range, 10 to 35 years) at the time of HCT and 34 years (range, 17 to 44 years) at the time of LT, with a median interval between HCT and LT of 10 years (range, 2.9 to 27 years). Indications for LT-included pulmonary fibrosis (n = 4), BOS (n = 3), interstitial pneumonitis related to graft-versus-host disease (GVHD) (n = 1), and primary pulmonary hypertension (n = 1). Median survival was 49 months (range, 2 weeks to 87 months), and 1 patient remains alive at more than 3 years after LT. Survival at 1 year and 5 years after LT was 89% and 37%, respectively. In the medical literature between 1992 and July 2013, we identified 20 articles describing 61 cases of LT after HCT from various centers in the United States, Europe, and Asia. Twenty-six of the 61 cases (43%) involved patients age <18 years at the time of LT. BOS and GVHD of the lung were cited as the indication for LT in the majority of cases (80%; n = 49), followed by pulmonary fibrosis and interstitial lung disease (20%; n = 12). In publications reporting 3 or more cases with a follow-up interval ranging from the immediate postoperative period to 16 years, the survival rate was 71% (39 of 55). Most deaths were attributed to long-term complications of the lung allograft, including infections and BOS. Two deaths were related to recurrent or relapsed hematologic malignancy. LT can prolong survival in some patients who suffer from end-stage pulmonary complications after HCT. Patient factors that likely improve the chances of a good long-term outcome include young age, at least 2 years post-HCT free of relapse from the original hematologic malignancy, and lack of other end-organ dysfunction or manifestations of chronic GVHD that require treatment with immunosuppressive agents." @default.
• W2023642966 created "2016-06-24" @default.
• W2023642966 creator A5002048183 @default.
• W2023642966 creator A5016644532 @default.
• W2023642966 creator A5036231700 @default.
• W2023642966 creator A5037474143 @default.
• W2023642966 creator A5059063645 @default.
• W2023642966 date "2014-08-01" @default.
• W2023642966 modified "2023-10-14" @default.
• W2023642966 title "Outcomes of Lung Transplantation after Allogeneic Hematopoietic Stem Cell Transplantation" @default.
• W2023642966 cites W1773225931 @default.
• W2023642966 cites W1971181528 @default.
• W2023642966 cites W1978820949 @default.
• W2023642966 cites W1980656682 @default.
• W2023642966 cites W1981631137 @default.
• W2023642966 cites W1990102711 @default.
• W2023642966 cites W1990284922 @default.
• W2023642966 cites W1995090169 @default.
• W2023642966 cites W1996446218 @default.
• W2023642966 cites W1999638064 @default.
• W2023642966 cites W2000262894 @default.
• W2023642966 cites W2007737041 @default.
• W2023642966 cites W2013957295 @default.
• W2023642966 cites W2029992098 @default.
• W2023642966 cites W2037182528 @default.
• W2023642966 cites W2037364146 @default.
• W2023642966 cites W2038485127 @default.
• W2023642966 cites W2055242738 @default.
• W2023642966 cites W2057149007 @default.
• W2023642966 cites W2067430956 @default.
• W2023642966 cites W2074628485 @default.
• W2023642966 cites W2083451680 @default.
• W2023642966 cites W2083679849 @default.
• W2023642966 cites W2084332691 @default.
• W2023642966 cites W2094942367 @default.
• W2023642966 cites W2096478453 @default.
• W2023642966 cites W2099508916 @default.
• W2023642966 cites W2106429556 @default.
• W2023642966 cites W2131907362 @default.
• W2023642966 cites W2161508292 @default.
• W2023642966 cites W2170917109 @default.
• W2023642966 cites W2328820789 @default.
• W2023642966 cites W2770847249 @default.
• W2023642966 cites W2917040507 @default.
• W2023642966 doi "https://doi.org/10.1016/j.bbmt.2014.04.008" @default.
• W2023642966 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/24727334" @default.
• W2023642966 hasPublicationYear "2014" @default.
• W2023642966 type Work @default.
• W2023642966 sameAs 2023642966 @default.
• W2023642966 citedByCount "43" @default.
• W2023642966 countsByYear W20236429662015 @default.
• W2023642966 countsByYear W20236429662016 @default.
• W2023642966 countsByYear W20236429662017 @default.
• W2023642966 countsByYear W20236429662018 @default.
• W2023642966 countsByYear W20236429662019 @default.
• W2023642966 countsByYear W20236429662020 @default.
• W2023642966 countsByYear W20236429662021 @default.
• W2023642966 countsByYear W20236429662022 @default.
• W2023642966 countsByYear W20236429662023 @default.
• W2023642966 crossrefType "journal-article" @default.
• W2023642966 hasAuthorship W2023642966A5002048183 @default.
• W2023642966 hasAuthorship W2023642966A5016644532 @default.
• W2023642966 hasAuthorship W2023642966A5036231700 @default.
• W2023642966 hasAuthorship W2023642966A5037474143 @default.
• W2023642966 hasAuthorship W2023642966A5059063645 @default.
• W2023642966 hasBestOaLocation W20236429661 @default.
• W2023642966 hasConcept C126322002 @default.
• W2023642966 hasConcept C141071460 @default.
• W2023642966 hasConcept C2776739411 @default.
• W2023642966 hasConcept C2777408962 @default.
• W2023642966 hasConcept C2777714996 @default.
• W2023642966 hasConcept C2781448352 @default.
• W2023642966 hasConcept C2911091166 @default.
• W2023642966 hasConcept C71924100 @default.
• W2023642966 hasConcept C90924648 @default.
• W2023642966 hasConceptScore W2023642966C126322002 @default.
• W2023642966 hasConceptScore W2023642966C141071460 @default.
• W2023642966 hasConceptScore W2023642966C2776739411 @default.
• W2023642966 hasConceptScore W2023642966C2777408962 @default.
• W2023642966 hasConceptScore W2023642966C2777714996 @default.
• W2023642966 hasConceptScore W2023642966C2781448352 @default.
• W2023642966 hasConceptScore W2023642966C2911091166 @default.
• W2023642966 hasConceptScore W2023642966C71924100 @default.
• W2023642966 hasConceptScore W2023642966C90924648 @default.
• W2023642966 hasIssue "8" @default.
• W2023642966 hasLocation W20236429661 @default.
• W2023642966 hasLocation W20236429662 @default.
• W2023642966 hasOpenAccess W2023642966 @default.
• W2023642966 hasPrimaryLocation W20236429661 @default.
• W2023642966 hasRelatedWork W1006981286 @default.
• W2023642966 hasRelatedWork W2008347710 @default.
• W2023642966 hasRelatedWork W2042577913 @default.
• W2023642966 hasRelatedWork W2091426432 @default.
• W2023642966 hasRelatedWork W2320341162 @default.
• W2023642966 hasRelatedWork W2329145628 @default.
• W2023642966 hasRelatedWork W2344986991 @default.
• W2023642966 hasRelatedWork W2404853076 @default.
• W2023642966 hasRelatedWork W2992364290 @default.

• next